拉帕替尼新中间体的合成

通过使用市售的5-溴糠醛与2-甲磺酰基乙胺进行亲和加成得到席夫碱,该席夫碱通过还原氢化、氨基保护和与硼酸酯反应,得到一种拉帕替尼的新中间体5-((苄基(2-(甲基磺酰基)乙基)氨基)甲基)呋喃-2-基硼酸,四步反应总收率为66.32%。     

Pd-PAN催化制备拉帕替尼中间体的研究

本文以N-(3-氯-4-((3-氟苯基)甲氧基)苯基)-6-碘喹唑啉-4-胺为起始原料,经自制聚苯胺负载钯催化剂(Pd-PAN)催化Suzuki偶联反应制备N-(3-氯-4-(3-氟苄氧基)苯基)-6-((5-甲酰基)呋喃-2-基)-4-喹唑啉胺。对Pd-PAN的结构和理化性能进行表征。通过正交实验确定最佳反应条件:80℃下,催化剂与底物质量比为1∶40,乙醇溶剂体系进行Suzuki偶联反应。Pd-PAN回收使用5次,产物的转化率保持在85%以上。以此中间体合成拉帕替尼,通过熔点测定、HPLC、质谱、~1H-NMR对终产物进行了结构确证。本工艺操作简单,产品质量稳定,适于工业扩大生产。     

伊马替尼衍生物的合成及其抗肿瘤活性

以4-硝基-2-氨基甲苯为起始原料,经加成、缩合、环化和还原反应制得中间体N-(2-甲基-5-氨基苯基)-4-(3-吡啶基)嘧啶-2-胺(4),再与取代酰氯反应,合成了7个新型伊马替尼衍生物（5a~5g）,其结构经¹H NMR, ¹³C NMR和HR-MS 表征。采用四甲基偶氮唑盐(MTT)法考察了5对人肝癌细胞(HepG₂)、子宫颈癌细胞（Hela）、肺癌细胞（H460）和乳腺癌细胞（MCF-7）体外抑制活性。结果显示：5e体外抑制活性最优,其IC₅₀分别为10.90±1.00 μmol·L^-1; 8.51±0.90 μmol·L^-1; 13.15±1.11 μmol·L^-1; 14.75±0.78 μmol·L^-1。     

新型4-取代苯胺喹唑啉衍生物的合成与抗肿瘤活性研究

以6-碘喹唑啉-4-酮为原料,经氯代、胺化、Suzuki偶联、Wittig-horner等反应合成了7个新型的4 取代苯胺喹唑啉衍生物(5a~5g),其结构经¹H NMR和HR-MS(ESI)表征。采用MTT法研究了5a~5g对人乳腺癌细胞(MCF-7)、人肺癌细胞(A549)和人皮肤鳞癌细胞（A431）的抑制活性。结果表明：5a~5g对肿瘤细胞均具有明显的抑制活性;其中5e的抑制活性(IC₅₀=0.13~5.26 μmol·L^-1)优于拉帕替尼(IC₅₀=0.21~15.56 μmol·L^-1)。     

伊马替尼衍生物的合成及细胞毒活性研究

以3-乙酰基嘧啶、2-甲基-5-硝基苯胺为起始原料,经加成、缩合、环化、还原得到中间体伊马替胺(6),再与异氰酸酯和芳酰基异硫氰酸酯胺解得到脲类(7a~7e)和芳酰基硫脲类(8a~8g)共12个化合物。目标化合物经过IR、1H NMR、13C NMR、HRMS等结构确证。采用四甲基偶氮唑盐(MTT)法考察目标化合物细胞毒活性,结果显示,目标化合物对所选肿瘤细胞的增殖活性具有一定抑制作用,其中化合物7d、7e、8d对人白血病细胞(K562)和人肝癌细胞(Hep G2)的抑制活性接近伊马替尼。     

抗肿瘤药物仑伐替尼合成研究进展

综述了仑伐替尼及其相关主要中间体的合成方法。首先对仑伐替尼逆合成分析,并着重讨论了喹啉环(原料1)以及终产物仑伐替尼的合成。原料1有四种合成方法,对这四种合成方法进行了详细对比与分析,指出第二种合成方法为最佳合成方法。总结了仑伐替尼最常用的两条合成路线并分析优缺点,第一条路线是汇聚式路线,反应时间短、能耗少、成本低、收率高,相比第二条路线更加适合工业化生产。     

抗肿瘤药布格替尼的合成

以2-碘苯胺为起始原料,经“一锅法”反应制得{2-[（2,5-二氯嘧啶-4-基）氨基]苯基}二甲基氧化膦（3）; 1-甲基-4-（哌啶-4基）哌嗪（4）与5-氟-2-硝基苯甲醚反应后,经氢化还原得2-甲氧基-4-[4-（4-甲基哌嗪-1-基）哌啶-1-基]-苯胺（6）; 3和6反应合成了布格替尼,总收率48.5%,纯度99.6%,其结构经¹H NMR和MS（ESI）确证。     

乐伐替尼的合成

以4-氨基-2-甲氧基苯甲酸甲酯为原料,与米氏酸、原甲酸三甲酯发生缩合得到4-[(2,2-二甲基-4,6-二氧代-1,3-二噁烷-5-亚甲基)氨基]-2-甲氧基苯甲酸甲酯(4),随后经环合、氯代、氨化反应生成4-氯-7-甲氧基喹啉-6-甲酰胺(7)。7与3-氯-4-氨基苯酚盐酸盐反应制得4-(4-氨基-3-氯苯氧基)-7-甲氧基喹啉-6-甲酰胺(8),最后与氯甲酸苯酯、环丙胺经一锅反应制得乐伐替尼。目标产物结构经核磁、质谱分析得到确证,总收率约34%(以4-氨基-2-甲氧基苯甲酸甲酯计)。改进后的工艺操作简单,降低了原料成本,且各步反应收率较高。     

新型含氟姜黄素类似物的合成、晶体结构及抗肿瘤活性

采用活性基团拼接法将含氟苯甲醛与酮反应, 合成了5个含氟单羰基姜黄素类似物, 结构经IR, ¹H NMR及ESI-MS确认. 对所合成的化合物进行了抗肿瘤活性测试(MTT法), 结果表明, 部分化合物对肿瘤细胞有较强的选择性抑制活性, 其中2,6-二(4-氟亚苯基)环己酮(3a)和2,6-二(2-氟亚苯基)环己酮(3b)的抗肿瘤谱广, 活性较好, 就此对化合物3b作了单晶培养, 并就晶体结构进行了X衍射分析. 结构表明化合物3b属三斜晶系, 空间群 P-1. 晶胞参数 a＝0.9222(2) nm, b＝0.9732(2) nm, c＝1.0127(2) nm, α＝88.920(4)°, β＝75.672(3)°, γ＝62.404(3)°, V＝0.7755(3) nm³, Z＝2, D_c＝1.329 Mg•m^－3, μ＝0.097 mm^－1, F(000)＝324, 最终偏离因子R＝0.0590, wR＝0.1841.     

吉非替尼的合成工艺改进

以3-羟基-4-甲氧基苯甲醛为原料,先与N-(3-氯丙基)吗啉缩合,后依次经过醛基转化为氰基、硝化、还原、与3-氯-4-氟苯胺环合等反应合成了抗肿瘤药物吉非替尼,总收率约50%。其结构经1H NMR,MS和元素分析表征。     

Synthesis and Primary Research on Antitumor Activity of Three New Panaxadiol Fatty Acid Esters

For making use of Ginseng resources that exhibit an antitumor activity and for finding new anticancer drugs,three new fatty acid ester compounds: 3β-acetoxy panaxadiol ( Ⅰ ), 3β-palmitic acid aceloxy panaxadiol ( Ⅱ ), and 3β-octadecanoic acid aceloxy panaxadiol( Ⅰ , Ⅱ , and Ⅲ ) were synthesized with panaxadiol, diacetyl oxide, palmityl chloride and stearyl chloride, and their structures were determined via MS, 13C NMR, IR, TLC, and so on. The molar yields of the three compounds are 75.14%, 79. 08%, and 72. 57%, respectively. Meanwhile, the antitumor activity of the three new panaxadiol fatty acid ester derivatives and panaxadiol was compared by using the method of MTT. Tumor cell used was Vero cell line. Positive control was 5-FU, blank was an RPMI1640 culture medium, negative control was an RPMI1640 culture medium and the solvent for drugs to be tested. Compound Ⅰ has the strongest antitumor activity followed by panaxadiol; compounds Ⅱ and Ⅲ have similar and weakest antitumor activities.Furthermore, the antitumor activities of the panaxadiol fatty acid ester derivatives show positive correlation with the concentration of the test group, but show no relationship with the molecular weight of fatty acid. The methods that are used to synthesize the three compounds with high yields and strong antitumor activities are simple and show a great potential for meeting the needs of industrial manufacture of these drugs.     

Synthesis and Antitumor Activity of Capecitabine Derivatives

A series of capecitabine derivatives with a Boc group at the N⁴-position was synthesized and their in vitro antitumor activities against HepG2(liver hepatocellular carcinoma) were primarily evaluated. Some compounds were chosen for further evaluation of their in vivo efficacy on nude mice xenografted human hepatoma HepG2. The results showed that compounds 3 and 6 had considerable in vivo activity against HepG2, with tumor growth inhibition rates of 70% and 64% on day 21, respectively, and 56% and 55% on day 35, respectively, which are roughly comparable to capecitabine(74% and 59% on days 21 and 35, respectively).     

喹喔啉-三唑衍生物的设计与合成及其抗肿瘤活性

喹喔啉和1,2,3-三唑都是具有广泛生物活性的杂环结构母体。本文基于药物设计的拼合原理,以简单易得的邻苯二胺、苯乙炔及有机叠氮为原料,通过三组分"两步一锅法"将喹喔啉和1,2,3-三唑活性亚结构进行拼接,合成了一系列共14个新型喹喔啉-三唑衍生物(3a~3n)。该法操作简单,无需分离中间体,两步总产率52.6%~78.4%。合成的目标化合物结构经~1H NMR、~(13)C NMR和HRMS确证。初步体外抗肿瘤活性测试表明,合成的目标化合物具有一定的抗肿瘤活性。     

2-苯基-苯并异硒唑酮-3及其衍生物的合成和抗肿瘤活性的初步研究

微量元素硒能防治克山病、大骨节病、肿瘤及心血管病等。目前,普遍认为在哺乳动物体内存在着一种重要的含硒酶即谷胱甘肽过氧化物酶(GSH-Px),阻由于其结构的复杂性,限制了对它的研究。而有关硒酶模拟化合物2-苯基-苯并异硒唑酮-3(简称Ebselen)的生物活性已见诸报道,它是具有类似谷胱甘肽过氧化物酶生物活性的小分子有机硒化合物,具有极     

Synthesis and Anti-tumor Activity of Novel Glycyrrhetinic Acid Derivatives

Twenty-five derivatives of glycyrrhetinic acid(GA)modified on the A-ring,at C30 and C11 positions were synthesized.Their in vitro cytotoxicity against various cancer cell lines[henrietta lacks strain o...     

甘草次酸衍生物的合成及其抗癌活性

设计合成了6种甘草次酸衍生物,用元素分析、波谱分析鉴定了它们的结构,并比较了它们的体内、体外抗癌活性,均表现出较好的活性,尤其是化合物Ⅰa,Ⅰb口服效果比盐酸氮芥还好,表现出甘草次酸对氮芥有明显的增效应用。     

二肽类膦酸酯衍生物的合成与抗肿瘤活性

为了寻找抗肿瘤活性化合物,以前期研究的含一个氨基酸结构单元的膦酸酯衍生物为基础,设计合成了15个二肽类膦酸酯衍生物(Ⅲa-Ⅲo).采用溴化噻唑蓝四氮唑(MTT)法进行体外抗肿瘤活性测试.结果表明:该类化合物对人肺癌细胞(A-549)、人胃癌细胞(SGC-7901))和人食管癌细胞(EC-109)有潜在增殖抑制作用.其中...     

Synthesis and Anti-tumor Activity of Novel Amide Derivatives of Ursolic Acid

Ursolic acid was modified at C3 and C28 position to obtain fourteen derivatives including twelve novel compounds, and their chemical structures were characterized by IR, ^1H NMR and MS. Cell growth inhibitory effects of the derivatives against Hela cell were evaluated by MTT assay. All these derivatives were found to have stronger cell growth inhibitory than their parent compound, ursolic acid. The derivatives with a substituted acetyl group at C3 hydroxyl group show better activities than those with an unsubstituted hydroxyl group.     

饶丹宁甲叉基取代左氧氟沙星衍生物的合成与抗肿瘤活性

为寻找提高氟喹诺酮肿瘤活的有效结构修饰策略,左氧氟沙星(3)的衍生物(S)-(-)-9-氟-2,3-二氢-3-甲基-10-(4-甲基-1-哌嗪基)-[1,4]噁嗪并[2,3,4-ij]-喹啉-7(4H)-酮-6-甲醛(5)与饶丹宁类(2a-2l)通过Claisen-Schmid缩合反应构建了饶丹宁甲叉基取代左氧氟沙星衍...     

Synthesis and Antitumor Activity of 7-Substituted Derivatives of Homocamptothecin

Camptotecin is the parent of an important class of anticancer agents which, can selectively poison the ubiquitous nuclear enzyme topoisomerase. Water soluble camptothecin analogues such as topotecan and irinotecan are already approved for clinical uses in…